Valuation: Uscom Limited

Market Cap 31.22L 21.65L 18.93L 17.39L 16.21L 30.75L 21Cr 2.09Cr 81.18L 10Cr 81.27L 79.52L 35Cr P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 44.19L 30.65L 26.79L 24.62L 22.95L 43.53L 29Cr 2.96Cr 1.15Cr 14Cr 1.15Cr 1.13Cr 49Cr EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.02
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.18
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-25.00%-73.91% 21.65L
+1.97%+2.03%+21.92%+0.83% 19TCr
+5.87%+5.27%-21.76%+26.78% 15TCr
+2.17%+0.89%-2.59%-16.42% 14TCr
+4.83%+2.06%-56.73%-15.69% 6.71TCr
+2.59%+3.95%+22.89%+3.15% 5.43TCr
+0.03%+2.19%-25.17%-31.30% 4.46TCr
+0.31%+1.30%+8.30%+43.25% 3.72TCr
-2.02%-3.91%+7.67%+9.53% 3.69TCr
+4.24%+4.66%-18.42%-2.34% 3.02TCr
Average +2.91%+2.47%-8.89%-5.61% 7.56TCr
Weighted average by Cap. +2.78%+3.44%-4.01%+2.00%

Financials

2024 2025
Net sales 37.27L 25.85L 22.6L 20.77L 19.36L 36.71L 25Cr 2.49Cr 96.91L 12Cr 97.02L 94.94L 42Cr 25.79L 17.88L 15.63L 14.37L 13.39L 25.4L 17Cr 1.72Cr 67.06L 8.37Cr 67.13L 65.69L 29Cr
Net income -20.75L -14.39L -12.58L -11.56L -10.78L -20.44L -14Cr -1.39Cr -53.95L -6.73Cr -54.01L -52.85L -23Cr -33.03L -22.91L -20.02L -18.4L -17.15L -32.53L -22Cr -2.21Cr -85.88L -11Cr -85.98L -84.13L -37Cr
Net Debt -15.31L -10.62L -9L -9L -8L -15.08L -10Cr -1.02Cr -39.8L -4.97Cr -39.85L -38.99L -17Cr 12.97L 9L 8L 7L 7L 12.78L 8.57Cr 86.76L 33.73L 4.21Cr 33.77L 33.04L 15Cr
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35